Citadel Advisors’s Aveanna Healthcare AVAH Stock Holding History

Citadel Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-400	Closed	-$2.17K	–	12484
2025 Q1	$2.17K	Sell	400 -3,500	-90%	-$16.5K	﹤0.01%	14059
2024 Q4	$17.8K	Sell	3,900 -100	-3%	-$512	﹤0.01%	13245
2024 Q3	$20.8K	Buy	4,000 +2,700	+208%	+$12.2K	﹤0.01%	12752
2024 Q2	$3.59K	Sell	1,300 -8,400	-87%	-$20.9K	﹤0.01%	13581
2024 Q1	$24.2K	Buy	+9,700	New	+$23.4K	﹤0.01%	12872
2023 Q4	–	Sell	-100	Closed	-$119	–	14237
2023 Q3	$119	Buy	+100	New	+$155	﹤0.01%	14159
2023 Q1	–	Sell	-9,600	Closed	-$7.49K	–	14682
2022 Q4	$7.49K	Buy	+9,600	New	+$10K	﹤0.01%	13820
2022 Q2	–	Sell	-15,400	Closed	-$53K	–	12835
2022 Q1	$53K	Buy	+15,400	New	+$83.6K	﹤0.01%	12753
2021 Q3	–	Sell	-10,600	Closed	-$131K	–	13776
2021 Q2	$131K	Buy	+10,600	New	+$126K	﹤0.01%	12653

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Citadel Advisors's AVAH Position: Q2 2026 in Review

Citadel Advisors increased its Aveanna Healthcare (AVAH) stake by 725% in Q2 2026, buying an estimated $14.2M and bringing the position to 2,285,756 shares worth $19.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

Citadel Advisors first reported a position in AVAH in Q2 2021 and has held it in 17 quarters since. 216 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Citadel Advisors held 2,285,756 shares of Aveanna Healthcare worth $19.6M as of Q2 2026.
Citadel Advisors bought 2,008,806 Aveanna Healthcare shares in Q2 2026, an estimated $14.2M.
Aveanna Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2618 holding.
Citadel Advisors first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 17 quarters since.
216 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.